(Q44106896)

29 November 2017

Pamidronate treatment in SAPHO syndrome (English)

1 reference

29 November 2017

S Guignard

1

1 reference

29 November 2017

Chantal Job-Deslandre

series ordinal

2

1 reference

29 November 2017

V Sayag-Boukris

series ordinal

3

1 reference

29 November 2017

André Kahan

series ordinal

4

1 reference

29 November 2017

1 June 2002

1 reference

29 November 2017

1 reference

29 November 2017

69

1 reference

29 November 2017

4

1 reference

29 November 2017

392-396

1 reference

SAPHO syndrome: a long-term follow-up study of 120 cases

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900419-0

7 January 2021

Palmoplantar pustulosis and sternocostoclavicular arthro-osteitis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900419-0

7 January 2021

Effect of liposomal and free bisphosphonates on the IL-1 beta, IL-6 and TNF alpha secretion from RAW 264 cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900419-0

7 January 2021

Cytotoxic and migration inhibitory effects of bisphosphonates on macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900419-0

7 January 2021

Inhibition of antigen-presenting cell function by alendronate in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900419-0

7 January 2021

Comparative antiinflammatory and bone protective effects of two diphosphonates in adjuvant arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900419-0

7 January 2021

Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900419-0

7 January 2021

10.1016/S1297-319X(02)00419-0

Identifiers

DOI

1 reference

29 November 2017

1 reference